Marker Therapeutics, Inc.
MRKR
$1.19
$0.00030.03%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 113.26% | 15.37% | -31.11% | -25.07% | -13.52% |
Total Receivables | 215.25% | -70.11% | 34.49% | 80.14% | 1,133.85% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -58.53% | -15.75% | 50.97% | -7.20% | -48.79% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 101.85% | -6.55% | -17.15% | -17.72% | -12.11% |
|
|||||
Total Current Assets | 101.85% | -6.55% | -17.15% | -17.72% | -12.11% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 101.85% | -6.55% | -17.15% | -17.72% | -12.11% |
|
|||||
Total Accounts Payable | -44.01% | 75.97% | -9.96% | 25.05% | -17.51% |
Total Accrued Expenses | 62.07% | 242.63% | -27.52% | -71.45% | 60.41% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 0.84% | -58.95% | -11.10% | 171.44% | -51.66% |
Total Other Current Liabilities | 0.84% | -58.95% | -11.10% | 171.44% | -51.66% |
Total Current Liabilities | 0.11% | 75.48% | -14.39% | -25.08% | 10.62% |
|
|||||
Total Current Liabilities | 0.11% | 75.48% | -14.39% | -25.08% | 10.62% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 0.11% | 75.48% | -14.39% | -25.08% | 10.62% |
|
|||||
Common Stock & APIC | 3.32% | 0.01% | 0.02% | 0.03% | 0.03% |
Retained Earnings | -0.87% | -0.52% | -0.50% | -0.55% | -0.65% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 149.12% | -23.22% | -17.69% | -16.11% | -15.89% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 149.12% | -23.22% | -17.69% | -16.11% | -15.89% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 149.12% | -23.22% | -17.69% | -16.11% | -15.89% |
|